Paul Tudor Jones’s Journey Medical DERM Stock Holding History

Paul Tudor Jones’s Portfolio DERM Stock Details DERM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-10,602	Closed	-$57K	–	2148
2021 Q4	$57K	Buy	+10,602	New	+$76.8K	﹤0.01%	2263

Other funds holding DERM

BRF

B. Riley Financial Los Angeles, California $434M AUM 751.56% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return

AFG

American Financial Group Cincinnati, Ohio $284M AUM 12.01% 1-Year Est. Return

MAG

Millrace Asset Group Berwyn, Pennsylvania $98.4M AUM 63.71% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Paul Tudor Jones's DERM Position: Q1 2022 in Review

Paul Tudor Jones sold out of Journey Medical (DERM) in Q1 2022, closing a stake of 10,602 shares — an estimated $57K sold.

Paul Tudor Jones first reported a position in DERM in Q4 2021 and held it in 1 quarter. The position peaked at $57K in Q4 2021. 14 funds tracked by Wall St. Rank hold DERM as of Q1 2022.

Paul Tudor Jones reported no remaining Journey Medical position as of Q1 2022 after selling out during the quarter.
Paul Tudor Jones sold 10,602 Journey Medical shares in Q1 2022, an estimated $57K.
Paul Tudor Jones first reported a position in Journey Medical in Q4 2021 and held it in 1 quarter.
Paul Tudor Jones's Journey Medical position peaked at $57K in Q4 2021.
14 funds tracked by Wall St. Rank held Journey Medical as of Q1 2022.

Based on Tudor Investment Corp's 13F filing for Q1 2022, filed 16 May 2022.